GLOW Peptide Dosing Protocol & Schedule Evidence-level notice No clinical trial has evaluated BPC-157 + TB-500 + GHK-Cu together
Common observation framework across an IGF-1 LR3 cycle Window Week 1 What's commonly tracked Fasting blood glucose, hypoglycemic symptoms, injection-site response What it tells you Hypoglycemia frequency was highest in the first month of Increlex treatment
It combines the naturally occurring peptide GHK-Cu, known for its role in cellular repair and collagen synthesis ( 1, 2, 3 ), with the regenerative properties of TB-500 ( 6, 7 ) and the healing support of BPC-157 ( 13, 14 )
Every dog is different, and results can vary
Side effects like reactions at the injection site are common
The immune system sits right under the gut lining, so gut inflammation can spill into the rest of the body